Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor. (2021)

First Author: Skwarska A

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.chembiol.2021.04.004

PubMed Identifier: 33910023

Publication URI: http://europepmc.org/abstract/MED/33910023

Type: Journal Article/Review

Volume: 28

Parent Publication: Cell chemical biology

Issue: 9

ISSN: 2451-9448